RAUL CORREA: Open Payments
NPI 1245905736 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 64 payments from 12 companies in 2025. Trend: 2023 $2,478 · 2024 $2,666 · 2025 $1,405
Food & beverage: $1,405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $355 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $210 |
| Teva Pharmaceuticals USA, Inc. | 8 | $177 |
| Corium, LLC | 9 | $166 |
| Janssen Pharmaceuticals, Inc | 1 | $119 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 3 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
Products named: VRAYLAR, CAPLYTA, UZEDY, Azstarys, SPRAVATO, COBENFY, Qelbree, Jornay PM.
Industry payments across TX — which companies pay providers there.
